Disruption of STAT5A and NMI signaling axis leads to ISG20-driven metastatic mammary tumors

• Published in: Oncogenesis (New York, NY) Vol. 10; no. 6; p. 45
• Main Authors: Alsheikh, Heba Allah M., Metge, Brandon J., Pruitt, Hawley C., Kammerud, Sarah C., Chen, Dongquan, Wei, Shi, Shevde, Lalita A., Samant, Rajeev S.
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 02-06-2021; Nature Publishing Group
• Subjects: 13; 13/95; 14; 14/5; 38; 631/67/1347; 631/67/322; 82; Alveoli; Apoptosis; Breast cancer; Cell Biology; Developmental plasticity; Epithelium; Exonuclease; Human Genetics; Interferon; Internal Medicine; Medicine; Medicine & Public Health; Metastases; Metastasis; Myc protein; Nmi protein; Oncology; Proteins; Puberty; rRNA; Tumors
• ISSN: 2157-9024; 2157-9024
• DOI: 10.1038/s41389-021-00333-y

Molecular dynamics of developmental processes are repurposed by cancer cells to support cancer initiation and progression. Disruption of the delicate balance between cellular differentiation and plasticity during mammary development leads to breast cancer initiation and metastatic progression. STAT5A is essential for differentiation of secretory mammary alveolar epithelium. Active STAT5A characterizes breast cancer patients for favorable prognosis. N-Myc and STAT Interactor protein (NMI) was initially discovered as a protein that interacts with various STATs; however, the relevance of these interactions to normal mammary development and cancer was not known. We observe that NMI protein is expressed in the mammary ductal epithelium at the onset of puberty and is induced in pregnancy. NMI protein is decreased in 70% of patient specimens with metastatic breast cancer compared to primary tumors. Here we present our finding that NMI and STAT5A cooperatively mediate normal mammary development. Loss of NMI in vivo caused a decrease in STAT5A activity in normal mammary epithelial as well as breast cancer cells. Analysis of STAT5A mammary specific controlled genetic program in the context of NMI knockout revealed ISG20 (interferon stimulated exonuclease gene 20, a protein involved in rRNA biogenesis) as an unfailing negatively regulated target. Role of ISG20 has never been described in metastatic process of mammary tumors. We observed that overexpression of ISG20 is increased in metastases compared to matched primary breast tumor tissues. Our observations reveal that NMI-STAT5A mediated signaling keeps a check on ISG20 expression via miR-17–92 cluster. We show that uncontrolled ISG20 expression drives tumor progression and metastasis.